share_log

Legend Biotech | 6-K: Legend Biotech Announces Exclusive Global License Agreement for Certain CAR-T Therapies Targeting DLL3

SEC announcement ·  Nov 13, 2023 21:30
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.